Digitalna platforma ima za cilj da konkretne inovacije i tehnološka rešenja, proizvedena od strane akademske i istraživačke zajednice, učini dostupnim privatnim kompanijama. Ovo je usluga za automatsko preuzimanje, sinhronizaciju, sortiranje i prikazivanje informacija sa velikih naučnih platformi kao što su Academia.edu, Google Scholar ili Researchers Gate sa platforme EmpowerHR4Inno. Platforma se inicijalno fokusira na prioritetne sektore, prehrambenu industriju, zdravstveni turizam, horizontalni IT prioritet i nacionalno proizvedena rešenja sa tendencijom daljeg razvoja. Sljedeće informacije se mogu naći:
  • Biblioteka kurseva sa objavljenim podsadržajem VoS-a, rezultatima, drugim rešenjima i digitalnim alatima i HR modelima;
  • Skup funkcija koje omogućavaju slanje novijih, objavljenih članaka, radova korisnicima koji se registruju kao zainteresovani za određenu grupu vesti.
Journal of Medicine and Palliative Care
Associations of hsCRP, anthropometric, and biochemical parameters with cardiovascular risk in menopause status: a cross-sectional study
Aims: Cardiovascular disease (CVD) risk increases significantly after menopause, partly due to hormonal changes leading to abdominal obesity, dyslipidemia, and low-grade inflammation. High-sensitivity C-reactive protein (hsCRP) is a well-established biomarker of subclinical inflammation, yet its associations with anthropometric and biochemical parameters in menopausal women remain incompletely defined. To evaluate cardiovascular risk across hsCRP-based subgroups in menopausal women and identify...
Preuzmite dokument 2025 Filiz Mercantepe , Aleksandra Klisic , Alev Lazoğlu Özkaya , Elma Kalac
MDPI AG
Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) commonly coexists with type 2 diabetes (T2D), but their independent contributions to redox imbalance, inflammation and immune signaling remain uncertain. Objectives: This study aimed to evaluate whether the presence of MASLD alone, and the presence of T2D within MASLD, are independently associated with high-risk profiles of oxidative/antioxidant markers, peripheral blood mononuclear cell (PBMC) gene expression and adipocytokines....
Preuzmite dokument 2025 Sanja Erceg , Miron Sopić , Boško Misita , Miloš Mitrović , Jelena Kotur-Stevuljevic , Aleksandra Klisic , Milica Mamić , Ana Ninic , Jelena Munjas , Omar Ben Mariem , Ratko Tomašević ... Pogledajte sve
MDPI AG
SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era
Cardiovascular (CV) disease, chronic kidney disease, obesity, and diabetes mellitus have reached epidemic proportions over the past few decades. Accumulating evidence highlights the strong interconnection between these conditions, leading to the definition of a broader disease entity known as cardio-renal-metabolic (CRM) syndrome. This newly recognized clinical entity presents important challenges in identifying the optimal treatment strategy within a holistic, patient-centered framework. In line...
Preuzmite dokument 2025 Paschalis Karakasis , Efstratios Karagiannidis , Antonios P. Antoniadis , Nikolaos Fragakis , Athina Nasoufidou , Aleksandra Klisic , Konstantinos Grigoriou , Djordje S. Popovic , Panagiotis Stachteas , Dimitrios Patoulias , Barbara Fyntanidou ... Pogledajte sve
MDPI AG
Role of Interleukins in Type 1 and Type 2 Diabetes
Background: Despite distinct etiologies, type 1 diabetes (T1D) and type 2 diabetes (T2D) share chronic inflammation as a core feature. Interleukins, key immune mediators, play important yet still not fully understood roles in the development and complications of both conditions. Objective: This narrative review aims to provide a comprehensive and critical synthesis of current evidence on the role of key interleukins in T1D and T2D, highlighting their immunological functions, genetic associations,...
Preuzmite dokument 2025 Filiz Mercantepe , Sana Rafaqat , Saira Rafaqat , Aleksandra Klisic , Roha Asif , Ammara Khalid , Tolga Mercantepe
MDPI AG
Association of Serum Selenium with Clinical Features and Inflammatory and Oxidative Stress Markers in Iranian Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease—A Cross-Sectional Study
Background: There are conflicting epidemiological studies regarding the association between selenium (Se) and metabolic disorders. Furthermore, the pathophysiological links between Se and metabolic dysfunction-associated steatotic liver disease (MASLD) have not yet been fully elucidated. Therefore, we evaluated the association between serum Se levels and the clinical features of MASLD and the inflammatory and oxidative stress markers in these patients as potential risk factors for the progression...
Preuzmite dokument 2025 Reza Sharifi , Abbas Pishdadian , Soudabeh Hamedi-Shahraki , Aleksandra Klisic , Farshad Amirkhizi , Adele Shafaghi
MDPI AG
The Potential Role of sPD-L1 as a Predictive Biomarker in EGFR-Positive Non-Small-Cell Lung Cancer
Background/Objectives: A significant breakthrough in non-small-cell lung cancer (NSCLC) treatment has occurred with the introduction of targeted therapies and immunotherapy. However, not all patients treated with these therapies would respond to treatment, and patients who respond to treatment would acquire resistance at some time point. This is why we need new biomarkers that can predict response to therapy. The aim of this study was to investigate whether soluble programmed cell death-ligand 1...
Preuzmite dokument 2025 Ivan Soldatović , Damir Radončić , Biljana Šeha , Dragana Jovanović , Milan Savić , Natalija Samardžić , Aleksandra Klisic , Jelena Kotur Stevuljević , Milija Gajić , Marina Roksandić Milenković , Nikola Čolić , Katarina Lukić , Vesna Ceriman Krstic ... Pogledajte sve
Wiley
Sodium‐glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta‐analysis
AbstractBackgroundTransthyretin amyloid cardiomyopathy (ATTR‐CM) commonly leads to heart failure but has traditionally been an exclusion criterion in randomized clinical trials (RCTs) of sodium‐glucose cotransporter 2 inhibitors (SGLT2i); therefore, the effects of these drugs in this population remain undocumented. In light of recent studies, this meta‐analysis aimed to investigate the effect of SGLT2i on the prognosis of patients with ATTR‐CM.MethodsA comprehensive search of Medline, Scopus, and...
Preuzmite dokument 2025 Paschalis Karakasis , Panagiotis Theofilis , Manfredi Rizzo , Nikolaos Fragakis , Panayotis K Vlachakis , Aleksandra Klisic , Dimitrios Patoulias , Art Schuermans
Partneri
Pretplatite se na repozitorijum